12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Pollinex Quattro Grass: Development ongoing

Allergy Therapeutics expects FDA to lift a clinical hold on its Pollinex Quattro allergy vaccines "in the coming weeks" based on a meeting with the agency. The Pollinex Quattro program has been on hold in the U.S. since 2007 following a report of a rare neurological adverse event in a Phase III trial. Pollinex Quattro is a...

Read the full 264 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >